AirSculpt Technologies, Inc. (NASDAQ:AIRS) CEO Dennis Dean Sells 7,719 Shares

AirSculpt Technologies, Inc. (NASDAQ:AIRS) CEO Dennis Dean sold 7,719 shares of AirSculpt Technologies stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $7.53, for a total value of $58,124.07. Following the completion of the sale, the chief executive officer now directly owns 628,940 shares in the company, valued at $4,735,918.20. This represents a 1.21 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Dennis Dean also recently made the following trade(s):

• On Friday, November 15th, Dennis Dean sold 24,510 shares of AirSculpt Technologies stock. The shares were sold at an average price of $6.54, for a total transaction of $160,295.40.

AirSculpt Technologies Stock Down 6.5 %

AirSculpt Technologies stock opened at $6.51 on Friday. AirSculpt Technologies, Inc. has a fifty-two week low of $2.92 and a fifty-two week high of $9.20. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.86 and a current ratio of 0.51. The firm has a 50 day moving average price of $5.55 and a 200 day moving average price of $4.75. The company has a market capitalization of $376.81 million, a PE ratio of -46.50 and a beta of 1.57.

AirSculpt Technologies (NASDAQ:AIRS) last announced its quarterly earnings data on Friday, November 8th. The company reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.05). The business had revenue of $42.55 million during the quarter, compared to analyst estimates of $42.49 million. AirSculpt Technologies had a negative net margin of 4.13% and a positive return on equity of 2.22%. During the same quarter last year, the firm posted ($0.01) EPS. Research analysts expect that AirSculpt Technologies, Inc. will post 0.15 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, BTIG Research started coverage on shares of AirSculpt Technologies in a research report on Thursday, October 17th. They set a “neutral” rating for the company. Five investment analysts have rated the stock with a hold rating, According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $5.50.

Institutional Investors Weigh In On AirSculpt Technologies

Several large investors have recently bought and sold shares of AIRS. Barclays PLC raised its stake in AirSculpt Technologies by 227.0% in the third quarter. Barclays PLC now owns 19,100 shares of the company’s stock valued at $97,000 after buying an additional 13,259 shares in the last quarter. FourWorld Capital Management LLC purchased a new stake in shares of AirSculpt Technologies in the first quarter valued at about $557,000. Geode Capital Management LLC raised its stake in AirSculpt Technologies by 6.4% during the 3rd quarter. Geode Capital Management LLC now owns 355,540 shares of the company’s stock valued at $1,803,000 after acquiring an additional 21,339 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of AirSculpt Technologies by 1.0% during the first quarter. Vanguard Group Inc. now owns 576,038 shares of the company’s stock worth $3,537,000 after purchasing an additional 5,606 shares during the period. Finally, SW Investment Management LLC lifted its stake in shares of AirSculpt Technologies by 5.0% in the 2nd quarter. SW Investment Management LLC now owns 4,500,000 shares of the company’s stock worth $18,000,000 after acquiring an additional 213,677 shares during the period. Hedge funds and other institutional investors own 91.54% of the company’s stock.

About AirSculpt Technologies

AirSculpt Technologies, Inc, together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure.